 | | LAQ | | Name: | 5'-O-[(R)-({5-[(3R)-1,2-DITHIOLAN-3-YL]PENTANOYL}OXY)(HYDROXY)PHOSPHORYL]ADENOSINE | | Formula: | C18 H26 N5 O8 P S2 | | SMILES: | O=P(O)(OCC3OC(n1c2ncnc(N)c2nc1)C(O)C3O)OC(=O)CCCCC4SSCC4 | | InChi: | InChI=1S/C18H26N5O8PS2/c19-16-13-17(21-8-20-16)23(9-22-13)18-15(26)14(25)11(30-18)7-29-32(27,28)31-12(24)4-2-1-3-10-5-6-33-34-10/h8-11,14-15,18,25-26H,1-7H2,(H,27,28)(H2,19,20,21)/t10-,11-,14-,15-,18-/m1/s1 | | Synonyms: | LIPOYL-AMP | | Definition date: | 2006-12-27 | | Last modified: | 2021-03-01 | | Identifier: | 5'-O-[(R)-({5-[(3R)-1,2-dithiolan-3-yl]pentanoyl}oxy)(hydroxy)phosphoryl]adenosine |
|
 | | LAS | | Name: | N-acetyl-S-({(2R,3S,4R)-3-hydroxy-2-[(1S)-1-hydroxy-2-methylpropyl]-4-methyl-5-oxopyrrolidin-2-yl}carbonyl)cysteine | | Formula: | C15 H24 N2 O7 S | | SMILES: | O=C1NC(C(=O)SCC(C(=O)O)NC(=O)C)(C(O)C1C)C(O)C(C)C | | InChi: | InChI=1S/C15H24N2O7S/c1-6(2)10(19)15(11(20)7(3)12(21)17-15)14(24)25-5-9(13(22)23)16-8(4)18/h6-7,9-11,19-20H,5H2,1-4H3,(H,16,18)(H,17,21)(H,22,23)/t7-,9?,10+,11+,15-/m1/s1 | | Synonyms: | LACTACYSTIN | | Definition date: | 2008-07-10 | | Last modified: | 2021-03-01 | | Identifier: | N-acetyl-S-({(2R,3S,4R)-3-hydroxy-2-[(1S)-1-hydroxy-2-methylpropyl]-4-methyl-5-oxopyrrolidin-2-yl}carbonyl)cysteine |
|
 | | 5TR | | Name: | [(2~{E},6~{E},10~{E},14~{E},18~{Z},22~{E},26~{Z},30~{E},34~{E},38~{E})-3,7,11,15,19,23,27,31,35,39,43-undecamethyltetratetraconta-2,6,10,14,18,22,26,30,34,38,42-undecaenyl] dihydrogen phosphate | | Formula: | C55 H91 O4 P | | SMILES: | CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCO[P](O)(O)=O | | InChi: | InChI=1S/C55H91O4P/c1-45(2)23-13-24-46(3)25-14-26-47(4)27-15-28-48(5)29-16-30-49(6)31-17-32-50(7)33-18-34-51(8)35-19-36-52(9)37-20-38-53(10)39-21-40-54(11)41-22-42-55(12)43-44-59-60(56,57)58/h23,25,27,29,31,33,35,37,39,41,43H,13-22,24,26,28,30,32,34,36,38,40,42,44H2,1-12H3,(H2,56,57,58)/b46-25+,47-27+,48-29+,49-31-,50-33+,51-35-,52-37+,53-39+,54-41+,55-43+ | | Synonyms: | Undecaprenyl phosphate | | Definition date: | 2015-11-30 | | Last modified: | 2021-03-01 | | Release date: | 2016-02-17 | | Identifier: | [(2~{E},6~{E},10~{E},14~{E},18~{Z},22~{E},26~{Z},30~{E},34~{E},38~{E})-3,7,11,15,19,23,27,31,35,39,43-undecamethyltetratetraconta-2,6,10,14,18,22,26,30,34,38,42-undecaenyl] dihydrogen phosphate |
|
 | | LAZ | | Name: | N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE | | Formula: | C9 H10 Cl N O2 | | SMILES: | O=C(c1ccc(Cl)cc1)NCCO | | InChi: | InChI=1S/C9H10ClNO2/c10-8-3-1-7(2-4-8)9(13)11-5-6-12/h1-4,12H,5-6H2,(H,11,13) | | Synonyms: | 4-CHLORO-N-(2-HYDROXYETHYL)BENZAMIDE | | Definition date: | 2003-07-08 | | Last modified: | 2021-03-01 | | Identifier: | 4-chloro-N-(2-hydroxyethyl)benzamide |
|
 | | XAM | | Name: | (1R,4aS,5S,6S,8aR)-5-{[(5S)-1-(3-O-acetyl-4-O-carbamoyl-6-deoxy-2-O-methyl-alpha-L-talopyranosyl)-4-hydroxy-2-oxo-5-(propan-2-yl)-2,5-dihydro-1H-pyrrol-3-yl]carbonyl}-6-methyl-4-methylidene-1,2,3,4,4a,5,6,8a-octahydronaphthalen-1-yl 2,6-dideoxy-3-C-[(1S)-1-{[(3,4-dichloro-5-methyl-1H-pyrrol-2-yl)carbonyl]amino}ethyl]-beta-D-ribo-hexopyranoside | | Formula: | C44 H60 Cl2 N4 O14 | | SMILES: | O=C(OC1C(OC)C(OC(C)C1OC(=O)N)N2C(=O)C(=C(O)C2C(C)C)C(=O)C6C(C=CC5C(OC3OC(C(O)C(O)(C3)C(NC(=O)c4c(Cl)c(Cl)c(n4)C)C)C)CC/C(=C)C56)C)C | | InChi: | InChI=1S/C44H60Cl2N4O14/c1-16(2)33-35(53)29(41(56)50(33)42-38(59-10)37(62-23(9)51)36(20(6)61-42)64-43(47)57)34(52)28-18(4)11-13-24-25(14-12-17(3)27(24)28)63-26-15-44(58,39(54)21(7)60-26)22(8)49-40(55)32-31(46)30(45)19(5)48-32/h11,13,16,18,20-22,24-28,33,36-39,42,48,53-54,58H,3,12,14-15H2,1-2,4-10H3,(H2,47,57)(H,49,55)/t18-,20-,21+,22-,24-,25+,26-,27-,28-,33-,36+,37+,38+,39+,42+,44+/m0/s1 | | Synonyms: | Amycolamicin | | Definition date: | 2012-04-11 | | Last modified: | 2021-03-01 | | Release date: | 2014-07-16 | | Identifier: | (1R,4aS,5S,6S,8aR)-5-{[(5S)-1-(3-O-acetyl-4-O-carbamoyl-6-deoxy-2-O-methyl-alpha-L-talopyranosyl)-4-hydroxy-2-oxo-5-(propan-2-yl)-2,5-dihydro-1H-pyrrol-3-yl]carbonyl}-6-methyl-4-methylidene-1,2,3,4,4a,5,6,8a-octahydronaphthalen-1-yl 2,6-dideoxy-3-C-[(1S)-1-{[(3,4-dichloro-5-methyl-1H-pyrrol-2-yl)carbonyl]amino}ethyl]-beta-D-ribo-hexopyranoside |
|
 | | LC2 | | Name: | N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7,13-dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetraen-2-yl]-2-oxopropanamide | | Formula: | C25 H33 N O7 | | SMILES: | O=C(C(=O)NC2C=C(C=CC(O)CC=C(C=CC(O)CC1OC(=O)C2(C(=O)C1C)C)C)C)C | | InChi: | InChI=1S/C25H33NO7/c1-14-6-9-18(28)10-8-15(2)12-21(26-23(31)17(4)27)25(5)22(30)16(3)20(33-24(25)32)13-19(29)11-7-14/h6-8,10-12,16,18-21,28-29H,9,13H2,1-5H3,(H,26,31)/b10-8+,11-7+,14-6+,15-12+/t16-,18+,19-,20-,21-,25+/m1/s1 | | Synonyms: | Lankacidin C | | Definition date: | 2009-09-09 | | Last modified: | 2021-03-01 | | Identifier: | N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7,13-dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetraen-2-yl]-2-oxopropanamide |
|
 | | LCL | | Name: | 2,2-dichloro-N-[(1S,2S)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide | | Formula: | C11 H12 Cl2 N2 O5 | | SMILES: | O=[N+]([O-])c1ccc(cc1)C(O)C(NC(=O)C(Cl)Cl)CO | | InChi: | InChI=1S/C11H12Cl2N2O5/c12-10(13)11(18)14-8(5-16)9(17)6-1-3-7(4-2-6)15(19)20/h1-4,8-10,16-17H,5H2,(H,14,18)/t8-,9-/m0/s1 | | Synonyms: | L-Chloramphenicol | | Definition date: | 2012-08-16 | | Last modified: | 2021-03-01 | | Release date: | 2013-05-08 | | Identifier: | 2,2-dichloro-N-[(1S,2S)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide |
|
 | | LCM | | Name: | N,N'-butane-1,4-diylbis(2,3-dihydroxybenzamide) | | Formula: | C18 H20 N2 O6 | | SMILES: | O=C(c1cccc(O)c1O)NCCCCNC(=O)c2cccc(O)c2O | | InChi: | InChI=1S/C18H20N2O6/c21-13-7-3-5-11(15(13)23)17(25)19-9-1-2-10-20-18(26)12-6-4-8-14(22)16(12)24/h3-8,21-24H,1-2,9-10H2,(H,19,25)(H,20,26) | | Synonyms: | 4-LICAM | | Definition date: | 2013-01-22 | | Last modified: | 2021-03-01 | | Release date: | 2013-04-03 | | Identifier: | N,N'-butane-1,4-diylbis(2,3-dihydroxybenzamide) |
|
 | | XCA | | Name: | (8alpha,10alpha,25S)-3-hydroxycholesta-3,5-dien-26-oic acid | | Formula: | C27 H42 O3 | | SMILES: | O=C(O)C(C)CCCC(C)C4CCC3C1C(C2(C(=CC1)C=C(O)CC2)C)CCC34C | | InChi: | InChI=1S/C27H42O3/c1-17(6-5-7-18(2)25(29)30)22-10-11-23-21-9-8-19-16-20(28)12-14-26(19,3)24(21)13-15-27(22,23)4/h8,16-18,21-24,28H,5-7,9-15H2,1-4H3,(H,29,30)/t17-,18+,21+,22-,23+,24+,26+,27-/m1/s1 | | Synonyms: | (25S)-cholestenoic acid | | Definition date: | 2011-11-18 | | Last modified: | 2021-03-01 | | Identifier: | (8alpha,10alpha,25S)-3-hydroxycholesta-3,5-dien-26-oic acid |
|
 | | 5VO | | Name: | 6-oxidanylidene-6-phenyl-hexanoic acid | | Formula: | C12 H14 O3 | | SMILES: | OC(=O)CCCCC(=O)c1ccccc1 | | InChi: | InChI=1S/C12H14O3/c13-11(8-4-5-9-12(14)15)10-6-2-1-3-7-10/h1-3,6-7H,4-5,8-9H2,(H,14,15) | | Synonyms: | 5-Benzoylpentanoic Acid | | Definition date: | 2015-12-10 | | Last modified: | 2021-03-01 | | Release date: | 2015-12-23 | | Identifier: | 6-oxidanylidene-6-phenyl-hexanoic acid |
|
 | | 5VQ | | Name: | 2-Propen-1-ol | | Formula: | C3 H6 O | | SMILES: | OCC=C | | InChi: | InChI=1S/C3H6O/c1-2-3-4/h2,4H,1,3H2 | | Synonyms: | allyl alcohol | | Definition date: | 2015-12-11 | | Last modified: | 2021-03-01 | | Release date: | 2016-04-06 | | Identifier: | prop-2-en-1-ol |
|
 | | CEI | | Name: | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN-2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | | Formula: | C25 H21 N3 O3 | | SMILES: | O=C(Nc1ncc(nc1Cc2ccccc2)c3ccc(O)cc3)Cc4ccc(O)cc4 | | InChi: | InChI=1S/C25H21N3O3/c29-20-10-6-18(7-11-20)15-24(31)28-25-22(14-17-4-2-1-3-5-17)27-23(16-26-25)19-8-12-21(30)13-9-19/h1-13,16,29-30H,14-15H2,(H,26,28,31) | | Synonyms: | COELENTERAMIDE | | Definition date: | 2004-01-26 | | Last modified: | 2021-03-01 | | Identifier: | N-[3-benzyl-5-(4-hydroxyphenyl)pyrazin-2-yl]-2-(4-hydroxyphenyl)acetamide |
|
 | | CEN | | Name: | 7BETA-(4CARBOXYBUTANAMIDO) CEPHALOSPORANIC ACID | | Formula: | C15 H18 N2 O8 S | | SMILES: | O=C2N1C(=C(CSC1C2NC(=O)CCCC(=O)O)COC(=O)C)C(=O)O | | InChi: | InChI=1S/C15H18N2O8S/c1-7(18)25-5-8-6-26-14-11(13(22)17(14)12(8)15(23)24)16-9(19)3-2-4-10(20)21/h11,14H,2-6H2,1H3,(H,16,19)(H,20,21)(H,23,24)/t11-,14-/m1/s1 | | Synonyms: | GLUTARYL 7-AMINO CEPHALOSPORANIC ACID | | Definition date: | 2001-01-19 | | Last modified: | 2021-03-01 | | Identifier: | (6R,7R)-3-[(acetyloxy)methyl]-7-[(4-carboxybutanoyl)amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
|
 | | CEO | | Name: | 5-METHYLENE-2-[2-OXO-1-(2-THIOPHEN-2-YL-ACETYLAMINO)-ETHYL]-5,6-DIHYDRO-2H-[1,3]THIAZINE-4-CARBOXYLIC ACID | | Formula: | C14 H14 N2 O4 S2 | | SMILES: | O=CC(NC(=O)Cc1sccc1)C2N=C(C(=C)CS2)C(=O)O | | InChi: | InChI=1S/C14H14N2O4S2/c1-8-7-22-13(16-12(8)14(19)20)10(6-17)15-11(18)5-9-3-2-4-21-9/h2-4,6,10,13H,1,5,7H2,(H,15,18)(H,19,20)/t10-,13-/m1/s1 | | Synonyms: | HYDROLYZED CEPHALOTHIN | | Definition date: | 2002-02-11 | | Last modified: | 2021-03-01 | | Identifier: | (2R)-5-methylidene-2-{(1R)-2-oxo-1-[(thiophen-2-ylacetyl)amino]ethyl}-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
|
 | | XDM | | Name: | ~{N}-[(3-chlorophenyl)methyl]-4-ethanoyl-3-ethyl-5-methyl-1~{H}-pyrrole-2-carboxamide | | Formula: | C17 H19 Cl N2 O2 | | SMILES: | CCc1c([nH]c(C)c1C(C)=O)C(=O)NCc2cccc(Cl)c2 | | InChi: | InChI=1S/C17H19ClN2O2/c1-4-14-15(11(3)21)10(2)20-16(14)17(22)19-9-12-6-5-7-13(18)8-12/h5-8,20H,4,9H2,1-3H3,(H,19,22) | | Synonyms: | XDM1 | | Definition date: | 2016-08-13 | | Last modified: | 2021-03-01 | | Release date: | 2017-08-16 | | Identifier: | ~{N}-[(3-chlorophenyl)methyl]-4-ethanoyl-3-ethyl-5-methyl-1~{H}-pyrrole-2-carboxamide |
|
 | | XDN | | Name: | PIPERIDINE-3,4,5-TRIOL | | Formula: | C5 H11 N O3 | | SMILES: | OC1CNCC(O)C1O | | InChi: | InChI=1S/C5H11NO3/c7-3-1-6-2-4(8)5(3)9/h3-9H,1-2H2/t3-,4+,5+ | | Synonyms: | XYLOSE-DERIVED 1-DEOXY-NOJIRIMYCIN | | Definition date: | 2000-08-16 | | Last modified: | 2021-03-01 | | Identifier: | (3R,4r,5S)-piperidine-3,4,5-triol |
|
 | | CFB | | Name: | 2-CHLORO-9-(2-DEOXY-2-FLUORO-B -D-ARABINOFURANOSYL)-9H-PURIN-6-AMINE | | Formula: | C10 H11 Cl F N5 O3 | | SMILES: | Clc1nc(c2ncn(c2n1)C3OC(C(O)C3F)CO)N | | InChi: | InChI=1S/C10H11ClFN5O3/c11-10-15-7(13)5-8(16-10)17(2-14-5)9-4(12)6(19)3(1-18)20-9/h2-4,6,9,18-19H,1H2,(H2,13,15,16)/t3-,4+,6-,9-/m1/s1 | | Synonyms: | CLOFARABINE | | Definition date: | 2005-07-14 | | Last modified: | 2021-03-01 | | Identifier: | 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine |
|
 | | CFE | | Name: | (8R)-3-beta-D-ribofuranosyl-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol | | Formula: | C11 H16 N4 O5 | | SMILES: | OC[CH]1O[CH]([CH](O)[CH]1O)n2cnc3[CH](O)CNC=Nc23 | | InChi: | InChI=1S/C11H16N4O5/c16-2-6-8(18)9(19)11(20-6)15-4-14-7-5(17)1-12-3-13-10(7)15/h3-6,8-9,11,16-19H,1-2H2,(H,12,13)/t5-,6-,8-,9-,11-/m1/s1 | | Synonyms: | Coformycin | | Definition date: | 2010-01-26 | | Last modified: | 2021-03-01 | | Identifier: | (2R,3R,4S,5R)-2-[(8R)-8-hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]diazepin-3-yl]-5-(hydroxymethyl)oxolane-3,4-diol |
|
 | | 5YB | | Name: | N-(4-carbamimidoylbenzoyl)-beta-alanyl-L-alpha-aspartyl-L-phenylalanine | | Formula: | C24 H27 N5 O7 | | SMILES: | C(c1ccc(C(=N)N)cc1)(=O)NCCC(=O)NC(CC(=O)O)C(=O)NC(Cc2ccccc2)C(=O)O | | InChi: | InChI=1S/C24H27N5O7/c25-21(26)15-6-8-16(9-7-15)22(33)27-11-10-19(30)28-17(13-20(31)32)23(34)29-18(24(35)36)12-14-4-2-1-3-5-14/h1-9,17-18H,10-13H2,(H3,25,26)(H,27,33)(H,28,30)(H,29,34)(H,31,32)(H,35,36)/t17-,18-/m0/s1 | | Synonyms: | Ro-435054 | | Definition date: | 2016-01-05 | | Last modified: | 2021-03-01 | | Release date: | 2016-02-03 | | Identifier: | N-(4-carbamimidoylbenzoyl)-beta-alanyl-L-alpha-aspartyl-L-phenylalanine |
|
 | | CGO | | Name: | sodium 3,3'-(1E,1'E)-biphenyl-4,4'-diylbis(diazene-2,1-diyl)bis(4-aminonaphthalene-1-sulfonate) | | Formula: | C32 H22 N6 Na2 O6 S2 | | SMILES: | [Na+][O-]S(=O)(=O)c5cc(/N=N/c1ccc(cc1)c4ccc(/N=N/c3c(c2ccccc2c(c3)S(=O)(=O)[O-][Na+])N)cc4)c(N)c6c5cccc6 | | InChi: | InChI=1S/C32H24N6O6S2.2Na/c33-31-25-7-3-1-5-23(25)29(45(39,40)41)17-27(31)37-35-21-13-9-19(10-14-21)20-11-15-22(16-12-20)36-38-28-18-30(46(42,43)44)24-6-2-4-8-26(24)32(28)34 | | Synonyms: | congo red | | Definition date: | 2011-04-21 | | Last modified: | 2021-03-01 | | Identifier: | mu-{3,3'-[biphenyl-4,4'-diyldi(E)diazene-2,1-diyl]bis(4-aminonaphthalene-1-sulfonato-kappaO)(2-)}disodium |
|
 | | CGR | | Name: | CYCLIC GUANOSINE DIPHOSPHATE-RIBOSE | | Formula: | C15 H23 N5 O14 P2 | | SMILES: | O=C1C=2N3CN(C=2N=C(N)N1)C5OC(COP(=O)(O)OP(=O)(O)OCC4OC3C(O)C4O)C(O)C5O | | InChi: | InChI=1S/C15H23N5O14P2/c16-15-17-11-6(12(25)18-15)19-3-20(11)14-10(24)8(22)5(33-14)2-31-36(28,29)34-35(26,27)30-1-4-7(21)9(23)13(19)32-4/h4-5,7-10,13-14,21-24H,1-3H2,(H,26,27)(H,28,29)(H3,16,17,18,25)/t4-,5-,7-,8-,9-,10-,13-,14-/m1/s1 | | Synonyms: | CYCLIC GDP-RIBOSE | | Definition date: | 2006-12-11 | | Last modified: | 2021-03-01 | | Identifier: | (2R,3R,4S,5R,8S,10S,13R,14S,15R,16R)-20-amino-3,4,8,10,14,15-hexahydroxy-7,9,11,25,26-pentaoxa-1,17,19,21-tetraaza-8,10-diphosphapentacyclo[15.6.1.1~2,5~.1~13,16~.0~18,23~]hexacosa-18(23),19-dien-22-one 8,10-dioxide (non-preferred name) |
|
 | | CH5 | | Name: | 2-(((R)-2,3-DIHYDROXYPROPYL)PHOSPHORYLOXY)-N,N,N-TRIMETHYLETHANAMINIUM | | Formula: | C8 H21 N O6 P | | SMILES: | O=P(OCC(O)CO)(OCC[N+](C)(C)C)O | | InChi: | InChI=1S/C8H20NO6P/c1-9(2,3)4-5-14-16(12,13)15-7-8(11)6-10/h8,10-11H,4-7H2,1-3H3/p+1/t8-/m1/s1 | | Synonyms: | GLYCERO-3-PHOSPHOCHOLINE | | Definition date: | 2005-08-12 | | Last modified: | 2021-03-01 | | Identifier: | 2-{[(S)-{[(2R)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-N,N,N-trimethylethanaminium |
|
 | | CHU | | Name: | N-(3-fluoro-4-{[4-methyl-2-oxo-7-(pyrimidin-2-yloxy)-2H-chromen-3-yl]methyl}pyridin-2-yl)-N'-methylsulfuric diamide | | Formula: | C21 H18 F N5 O5 S | | SMILES: | O=S(=O)(NC)Nc1nccc(c1F)CC2=C(c4c(OC2=O)cc(Oc3ncccn3)cc4)C | | InChi: | InChI=1S/C21H18FN5O5S/c1-12-15-5-4-14(31-21-25-7-3-8-26-21)11-17(15)32-20(28)16(12)10-13-6-9-24-19(18(13)22)27-33(29,30)23-2/h3-9,11,23H,10H2,1-2H3,(H,24,27) | | Synonyms: | CH5126766 | | Definition date: | 2013-10-01 | | Last modified: | 2021-03-01 | | Release date: | 2014-06-04 | | Identifier: | N-(3-fluoro-4-{[4-methyl-2-oxo-7-(pyrimidin-2-yloxy)-2H-chromen-3-yl]methyl}pyridin-2-yl)-N'-methylsulfuric diamide |
|
 | | 607 | | Name: | 2-(2'-AMINO-5-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL-2-YL}-6-OXIDO-1,1'-BIPHENYL-3-YL)SUCCINATE | | Formula: | C24 H19 N5 O5 | | SMILES: | [O-]C(=O)CC(C([O-])=O)c4cc(c2nc1cc(ccc1n2)C(=[NH2+])N)c([O-])c(c3ccccc3N)c4 | | InChi: | InChI=1S/C24H21N5O5/c25-17-4-2-1-3-13(17)15-7-12(14(24(33)34)10-20(30)31)8-16(21(15)32)23-28-18-6-5-11(22(26)27)9-19(18)29-23/h1-9,14,32H,10,25H2,(H3,26,27)(H,28,29)(H,30,31)(H,33,34)/p-2/t14-/m1/s1 | | Synonyms: | CRA_18607 | | Definition date: | 2003-03-14 | | Last modified: | 2021-03-01 | | Identifier: | (2R)-2-(2'-amino-5-{5-[amino(iminio)methyl]-1H-benzimidazol-2-yl}-6-oxidobiphenyl-3-yl)butanedioate |
|
 | | XIF | | Name: | PIPERIDINE-3,4-DIOL | | Formula: | C5 H11 N O2 | | SMILES: | OC1CCNCC1O | | InChi: | InChI=1S/C5H11NO2/c7-4-1-2-6-3-5(4)8/h4-8H,1-3H2/t4-,5-/m1/s1 | | Synonyms: | XYLOSE-DERIVED ISOFAGOMINE | | Definition date: | 2000-08-17 | | Last modified: | 2021-03-01 | | Identifier: | (3R,4R)-piperidine-3,4-diol |
|
